Sunday, April 10, 2011 12:47:49 PM
Effective on March 30, 2011 (the “Closing Date”), pursuant to a Stock Purchase Agreement dated March 30, 2001 (the “Stock Purchase Agreement”), WellTek Incorporated (“WellTek” or the “Company”) acquired 100% of the issued and outstanding common stock of Stem Cells for Hope, Inc. in exchange for 15,000,000 of the Company’s issued and outstanding common stock. As of the Closing Date, Vladimir Kravchenko was appointed to the Board of Directors of WellTek and will serve as President of the Company and Peter Sidorenko will serve as Senior Vice President of the Company.
http://www.sec.gov/Archives/edgar/data/1456453/000095012311031550/c14966e8vk.htm
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM